We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock

Delisted

CERE was delisted on the 31st of July, 2024.

94 hedge funds and large institutions have $3.49B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 45 increasing their positions, 15 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more call options, than puts

Call options by funds: $17.4M | Put options by funds: $5.34M

200% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 15

75% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 16

32% more capital invested

Capital invested by funds: $2.64B → $3.49B (+$847M)

15% more funds holding

Funds holding: 8294 (+12)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
94
Holders Change
+12
Holders Change %
+14.63%
% of All Funds
1.65%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
28
Increased
45
Reduced
15
Closed
16
Calls
$17.4M
Puts
$5.34M
Net Calls
+$12.1M
Net Calls Change
+$3.49M
Name Holding Trade Value Shares
Change
Change in
Stake
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
26
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$5.74M +$5.46M +194,400 New
AA
27
ALPS Advisors
Colorado
$5.24M +$297K +10,582 +6%
TD Asset Management
28
TD Asset Management
Ontario, Canada
$5.15M +$558K +19,886 +13%
Point72 Asset Management
29
Point72 Asset Management
Connecticut
$4.17M -$6.38M -227,150 -62%
Swiss National Bank
30
Swiss National Bank
Switzerland
$2.75M +$654K +23,300 +33%
Voloridge Investment Management
31
Voloridge Investment Management
Florida
$2.72M +$2.59M +92,207 New
Rafferty Asset Management
32
Rafferty Asset Management
New York
$2.42M +$1.12M +40,059 +96%
Squarepoint
33
Squarepoint
New York
$2.22M +$2.12M +75,387 New
HighTower Advisors
34
HighTower Advisors
Illinois
$2.13M
Ensign Peak Advisors
35
Ensign Peak Advisors
Utah
$2.1M
AllianceBernstein
36
AllianceBernstein
Tennessee
$1.72M +$733K +26,100 +81%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$1.67M +$220K +7,846 +16%
PPA
38
Parametric Portfolio Associates
Washington
$1.64M +$602K +21,446 +63%
IC
39
Ikarian Capital
Texas
$1.57M +$1.5M +53,370 New
First Trust Advisors
40
First Trust Advisors
Illinois
$1.53M +$1.46M +51,997 New
EI
41
EAM Investors
California
$1.48M -$132K -4,703 -9%
LP
42
LMR Partners
United Kingdom
$1.48M +$1.4M +50,000 New
Wells Fargo
43
Wells Fargo
California
$1.38M +$1.32M +46,869 New
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$1.34M
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$1.32M +$845K +30,092 +207%
BC
46
Brookfield Corp
Ontario, Canada
$1.27M +$384K +13,690 +46%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$1.08M +$240K +8,540 +30%
Bank of America
48
Bank of America
North Carolina
$1.05M +$855K +30,466 +587%
UBS AM
49
UBS AM
Illinois
$982K +$934K +33,272 New
JP Morgan Chase
50
JP Morgan Chase
New York
$868K +$157K +5,595 +24%

CERE Hedge Fund Activity: Q3 2021 in Review

94 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2021, worth a combined $3.49B — up 32% from $2.64B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new CERE positions and 16 closed out — a net gain of 12 holders — while 45 added to existing stakes and 15 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $280M. The largest seller was RA Capital Management, exiting entirely with an estimated $56.4M sold.

  • 94 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2021, up from 82 in Q2 2021.
  • Funds reported $3.49B of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2021, up 32% quarter-over-quarter.
  • 28 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2021 and 16 closed out, a net change of +12 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2021 was Fidelity Investments, an estimated $280M added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q3 2021 was RA Capital Management, an estimated $56.4M sold.

Based on aggregated 13F filings for Q3 2021.